Search results
Results From The WOW.Com Content Network
The FTC's track record on pharma deals isn't great. It previously tried, unsuccessfully, to block Amgen’s ( AMGN ) $28 billion acquisition of Horizon Therapeutics.
Today we’re announcing that in our first year of negotiations we are saving Medicare $6 billion and Americans who pay out of pocket will be saving another $1.5 billion moving forward.
FDA approves Lilly's (LLY) selpercatinib for RET-altered lung and thyroid cancers and AstraZeneca (AZN)/Merck's (MRK) Lynparza for new ovarian cancer use.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Please help update this article to reflect recent events or newly available information. ... Chugai Pharmaceutical: Osteoporosis: Dec-1997: Jan-2013 93: Xeloda ...
It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline.
Moody's predicts a stable outlook for the pharmaceutical industry for the next year or so, even as it battles a number of headwinds. First, the headwinds.
An FDA panel recommends granting approval for emergency use of Pfizer's (PFE) COVID-19 vaccine. Glaxo (GSK)/Sanofi (SNY) COVID-19 vaccine plan delays.